| Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. | |
| | |
MedLine Citation:
|
PMID: 17949514 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Previous studies of smoking on dopamine release in humans were investigated only in smokers. Using nicotine gum, we examined the effect of nicotine on dopamine release in smokers and non-smokers and its relation to the degree of nicotine dependence. Smokers and non-smokers participated in a double-blind, randomized, placebo-controlled cross-over study. They participated in two PET measurements with [11C]raclopride, in which they received either nicotine or placebo. Changes in [11C]raclopride non-displaceable binding potential (BPND) following nicotine administration were quantified. Smokers showed significant decrease in BP in the striatum following nicotine administration, but non-smokers did not show such a decrease. The BPND difference between the two scanning sessions was correlated with the degree of nicotine dependence. The BPND difference might reflect enhanced dopamine release in smokers and the reinforced effect of nicotine. These data suggest the feasibility of our gum method as well as the importance of the degree of dependence in future studies of the nicotine effect on the dopamine system. |
| | |
Authors:
|
Hidehiko Takahashi; Yota Fujimura; Mika Hayashi; Harumasa Takano; Motoichiro Kato; Yoshiro Okubo; Iwao Kanno; Hiroshi Ito; Tetsuya Suhara |
Related Documents
:
|
19550414 - Effect of systemic alcohol and nicotine on airway protective reflexes. 6744784 - Nicotine and carbon monoxide intake from high- and low-yield cigarettes. 12692774 - Cigarette-derived nicotine is not a medicine. 2663534 - Pharmacological approach to smoking cessation. 21033644 - Life experiences and expectations of young women in uganda. 11788454 - Folates and cardiovascular disease. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't Date: 2007-10-22 |
Journal Detail:
|
Title: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) Volume: 11 ISSN: 1461-1457 ISO Abbreviation: Int. J. Neuropsychopharmacol. Publication Date: 2008 May |
Date Detail:
|
Created Date: 2008-04-02 Completed Date: 2008-08-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815893 Medline TA: Int J Neuropsychopharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 413-7 Citation Subset: IM |
Affiliation:
|
Department of Molecular Neuroimaging, National Institute of Radiological Sciences, Anagawa, Inage-ku, Chiba, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Dopamine
/
metabolism* Dopamine Antagonists / diagnostic use Double-Blind Method Humans Male Neostriatum / drug effects, radionuclide imaging Nicotine / administration & dosage, analogs & derivatives* Nicotinic Agonists / administration & dosage* Pilot Projects Polymethacrylic Acids / administration & dosage* Polyvinyls / administration & dosage* Positron-Emission Tomography Raclopride / diagnostic use Smoking / drug therapy*, metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Dopamine Antagonists; 0/Nicotinic Agonists; 0/Polymethacrylic Acids; 0/Polyvinyls; 54-11-5/Nicotine; 84225-95-6/Raclopride; 96055-45-7/nicotine polacrilex |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association between a common haplotype in the COMT gene region and psychiatric disorders in individu...
Next Document: Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a s...